z-logo
open-access-imgOpen Access
Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011
Author(s) -
Daniel C. Payne,
Julie A. Boom,
Mary Allen Staat,
Kathryn M. Edwards,
Peter G. Szilagyi,
Eileen J. Klein,
Rangaraj Selvarangan,
Parvin H. Azimi,
Christopher Harrison,
Mary E. Moffatt,
Samantha Johnston,
Leila C. Sahni,
Carol J. Baker,
Marcia A. Rench,
Stephanie Donauer,
Monica McNeal,
James D. Chappell,
Geoffrey A. Weinberg,
Azadeh Tasslimi,
Jacqueline E. Tate,
Mary E. Wikswo,
Aaron T. Curns,
Iddrisu Sulemana,
Slavica Mijatovic-Rustempasic,
Mathew D. Esona,
Michael D. Bowen,
Jon R. Gentsch,
Umesh D. Parashar
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit164
Subject(s) - rotavirus , medicine , rotavirus vaccine , confidence interval , vaccination , pediatrics , genotype , diarrhea , immunology , biology , gene , biochemistry
We assessed vaccine effectiveness (VE) for RotaTeq (RV5; 3 doses) and Rotarix (RV1; 2 doses) at reducing rotavirus acute gastroenteritis (AGE) inpatient and emergency department (ED) visits in US children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom